The [4 + 2] addition of singlet oxygen to thebaine: New access to highly functionalized morphine derivatives via opioid endoperoxides

Journal of Organic Chemistry

Volumn 65, Issue 15, 2000, Pages 4671-4678

  López, Dolores ^a   Quiñoá, Emilio ^a   Riguera, Ricardo ^a  

^a Santiago de Compostela Spain   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

14 HYDROXYCODEINONE; BENZOFURAN DERIVATIVE; BUPRENORPHINE; ENDOPEROXIDE; ETORPHINE; METHADONE; MORPHINE DERIVATIVE; NALOXONE; NARCOTIC ANALGESIC AGENT; OPIATE AGONIST; OXYCODONE; OXYMORPHONE; PREFIN; THEBAINE; TRAMADOL; UNCLASSIFIED DRUG;

ANALGESIA; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG ISOLATION; DRUG STRUCTURE; PAIN; PHOTOOXIDATION; PROTON NUCLEAR MAGNETIC RESONANCE;

BENZOFURANS; CODEINE; LIGHT; MAGNETIC RESONANCE SPECTROSCOPY; MERCURY; MORPHINE DERIVATIVES; NARCOTICS; OXIDANTS; OXYCODONE; OXYGEN; PEROXIDES; PHOTOCHEMISTRY; SINGLET OXYGEN; THEBAINE;

EID: 0343526760     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo000288a     Document Type: Article

References (32)

1. (a) Lenz, G. R.; Evans, S. M.; Walters, D. E.; Hopfinger, A. J.; Hammond, D. L. Opiates; Academic Press: Orlando, 1986.
2. (b) Casy, A. F.; Parfitt, R. T. Opioid Analgesics: Chemistry and Receptors; Plenum Press: New York, 1986.
3. (c) Central Analgetics; Lednicer, D., Ed.; John Wiley & Sons: New York, 1982.
4. (d) Zimmerman, D. M.; Leander J. D. J. Med. Chem. 1990, 33, 895.
5. (e) Bentley, K. W. The Alkaloids, Chemistry and Pharmacology; Manske, R. H. F., Holmes, H. L., Eds.; Academic Press: New York, 1971; Vol. XIII, p 75, and references therein.
6. (f) The Merck Index; 12th ed. on CD-ROM, ver. 12: 2; Chapman & Hall/CRCnetBASE.
7. Lewis, J. W. Discovery of Buprenorphine, a Potent Antagonist Analgesic. In Medicinal Chemistry. The Role of Organic Chemistry in Drug Research; Roberts, S. M., Price, B. J., Eds.; Academic Press: London, 1985; p 119, and references therein.
8. (a) Bentley, K. W.; Hardy, D. G.; Meek, B. J. Am. Chem. Soc. 1967, 89, 3273.
9. (b) id. J. Am. Chem. Soc 1967, 89, 3293.
10. (c) id. J. Am. Chem. Soc. 1967, 89, 3312.
11. Schmidhammer, H.; Schratz, A.; Schmidt, C.; Patel, D.; Traynor, J. R. Helv. Chim. Acta 1993, 76, 476.
12. Lindner, J. H. E.; Kuhn, H. J.; Gollnick, K. Tetrahedron Lett. 1972, 1705.
13. Schwartz, M. A.; Wallace, R. A. J. Med. Chem. 1981, 24, 1525.
14. Schwartz, M. A.; Wallace, R. A. Tetrahedron Lett. 1979, 3257.
15. López, D.; Quiñoá, E.; Riguera, R. Tetrahedron Lett. 1994, 35, 5727. Three patents have been issued: Riguera, R.; Quiñoá, E.; López, D., Patents P9602716, P9602717 and P9602718, 1996.
16. For a general reference on peroxides see: Clennan, E. L.; Foot, C. S. Endoperoxides. In Organic Peroxides; Ando, W., Ed.; Wiley: New York, 1992. See also: Akaeshi, T.; Ando, W. Peroxides from Photosentitized Oxidation of Hetero Atom Compounds. In Organic Peroxides; Ando, W., Ed.; Wiley: New York, 1992.
17. For a general reference on peroxides see: Clennan, E. L.; Foot, C. S. Endoperoxides. In Organic Peroxides; Ando, W., Ed.; Wiley: New York, 1992. See also: Akaeshi, T.; Ando, W. Peroxides from Photosentitized Oxidation of Hetero Atom Compounds. In Organic Peroxides; Ando, W., Ed.; Wiley: New York, 1992.
18. Bentley, K. W.; Hardy, D. G.; Meek, B. J. Am. Chem. Soc. 1967, 89, 3267.
19. (a) Phillipson, J. D.; Handa, S. S.; El-Dabbas, S. W. Phytochemistry 1978, 15, 1297.
20. (b) Theus, H. G.; Jansen, R. H. A. M.; Biessels, H. N. A.; Salemink, C. A. J. Chem. Soc., Perkin Trans. 1984, 1701.
21. (c) Caldwell, G. W.; Gautier, A. D.; Mills, J. E. Magn. Reson. Chem. 1996, 34, 505.
22. The stereoselectivity of Diels-Alder reactions of thebaine is known to produce exclusively the adducts formed at the less hindered face of the diene (see ref 1e). The transformation of 32 into 35 (a known compound), confirmed the assigned stereochemistry of 32.
23. The importance of the presence of free amino and hydroxy groups in opioids and their interactions with the opiate receptors is well documented, with numerous pharmacologically active derivatives incorporating such groups within their structures. See ref 1.
24. Reference 1c, pp 139-213.
25. Labidalle, S.; Zhang, Y. M.; Moskowitz, H.; Thal, C.; Miocque, M.; Degryse, M.; Fortin, M.; Delevallée, F. Eur. J. Med. Chem. 1989, 24, 385.
26. (a) Zhang, Y. M.; Boukaache, A.; Mayrargue, J.; Moskowitz, H.; Miocque, M.; Thal, C. Synth. Commun. 1992, 22, 1403.
27. (b) Labidalle, S.; Min, Z. Y.; Reynet, A.; Moskowitz, H.; Vierfond, J.-M.; Miocque, M. Tetrahedron 1988, 44, 1159.
28. (c) id. Tetrahedron 1988, 44, 1171.
29. (a) Salazar, L. A.; Martínez, R. V.; López-Muñoz, F. J. Drug Dev. Res. 1995, 36 (3), 119.
30. (b) Raffa, R. B. Am. J. Med. 1996, 101(1A), 40S.
31. (a) Kreek, M. J. Pharmacol. Biochem. Behav. 1997, 573, 551.
32. (b) Brackbill, R. M.; MacGowan, R. J.; Rugg, D. Am. J. Drug. Alcohol Abuse 1997, 233, 397.